A 5mg dose of Paxil (paroxetine) falls below the minimum therapeutic dose approved by the FDA for treating depression, anxiety, or any other psychiatric condition. The lowest FDA-approved starting dose for any condition is 12.5mg per day, used for panic disorder, social anxiety disorder, and premenstrual dysphoric disorder. For depression, the recommended starting dose is even higher at 25mg. That said, 5mg isn’t without purpose. It plays a recognized role in tapering off the medication and may have relevance at nearby doses for specific non-psychiatric conditions.
Why 5mg Falls Short for Depression and Anxiety
Paroxetine works by blocking the serotonin transporter, a protein that reabsorbs serotonin from the gaps between nerve cells. The more transporters you block, the more serotonin stays active in your brain. At 20mg per day, paroxetine blocks roughly 80% of these transporters, which is the threshold generally associated with antidepressant effects. At 5mg, transporter blockade is substantially lower, and the drug simply isn’t doing enough to produce a reliable antidepressant or anti-anxiety response in most people.
The FDA’s dosing recommendations reflect this. For major depressive disorder, the starting dose of the extended-release formulation (Paxil CR) is 25mg, with a maximum of 62.5mg. For panic disorder and social anxiety disorder, the starting dose is 12.5mg. Even for elderly patients or those with severe kidney or liver impairment, who metabolize the drug more slowly and need gentler dosing, the recommended starting point is 12.5mg. No approved indication starts at 5mg.
The One Exception: Hot Flashes
There is one area where very low doses of paroxetine have proven effective, though not quite at 5mg. A branded formulation called Brisdelle, dosed at 7.5mg per day, is FDA-approved specifically for treating hot flashes associated with menopause. At this dose, the drug reduces the frequency and severity of vasomotor symptoms without the side effects that often accompany higher doses. A randomized controlled trial found that 7.5mg of paroxetine did not cause weight gain or negative changes in libido over 24 weeks of use, both common complaints at standard antidepressant doses.
This 7.5mg dose is not approved for depression or anxiety. It targets a different problem through a mechanism that appears to involve the brain’s temperature regulation system rather than mood circuits. If your doctor has prescribed a dose in this range for hot flashes, that has clinical support behind it. But 5mg specifically has not been studied or approved for this purpose either.
Where 5mg Is Genuinely Useful: Tapering Off
The most common and well-supported reason someone might take 5mg of Paxil is as a step in gradually discontinuing the medication. Paroxetine is notorious for causing withdrawal symptoms, sometimes called discontinuation syndrome, which can include dizziness, nausea, electric shock sensations, irritability, and flu-like feelings. These symptoms can be severe, especially if the drug is stopped abruptly or reduced too quickly.
Research published in The Lancet Psychiatry found that when patients who experienced withdrawal symptoms during a standard taper were restarted and then tapered more slowly at 5mg reductions every two to four weeks, withdrawal symptoms were successfully avoided. In one study, this slower approach dropped the incidence of withdrawal from nearly 34% to under 5%.
The relationship between dose and brain effects is not linear. Dropping from 20mg to 15mg reduces serotonin transporter blockade by a modest amount, but dropping from 10mg to 5mg, or from 5mg to zero, produces a proportionally much larger change in brain chemistry. This is why people often struggle most at the tail end of a taper, when the doses seem tiny. A 5mg dose still provides meaningful serotonin transporter occupancy, and jumping from 5mg to nothing can be a difficult step for many people.
Some tapering protocols go even further, using doses as small as 0.5mg of paroxetine before stopping entirely. One large study of 895 patients using gradual tapering strips, which reduce medication to very small fractions of the standard dose, found that 71% were able to fully discontinue over a median of about eight weeks. Nearly all of these patients had previously failed to stop their medication due to withdrawal.
What 5mg Actually Does in Your Body
At 5mg, paroxetine is active in your system. It is blocking some serotonin transporters, just not enough to treat depression or anxiety reliably. Think of it as a partial effect: enough to prevent the shock of sudden withdrawal if you’re tapering, but not enough to function as a therapeutic dose for mood or anxiety disorders.
Some people report feeling better at very low doses, and individual variation in drug metabolism is real. A small number of people are slow metabolizers, meaning their bodies process paroxetine more gradually and effectively maintain higher blood levels from a given dose. But prescribing guidelines are based on what works for most people, and 5mg consistently falls below that threshold for psychiatric conditions.
If You’re Taking 5mg Right Now
If you’re on 5mg as part of a tapering plan, you’re following a well-supported strategy for minimizing withdrawal. The goal is typically to stay at each step long enough for your brain to adjust before reducing further.
If you’re taking 5mg hoping it will treat depression or anxiety, the evidence suggests it’s unlikely to be sufficient. The lowest dose with clinical support for any psychiatric indication is 12.5mg, and most people with depression need 20mg or more to see meaningful improvement. A dose that low may produce some side effects, like mild sedation or GI changes, without delivering the intended benefit.
If someone prescribed 5mg as a starting dose with plans to increase, that’s a cautious approach sometimes used to minimize initial side effects before moving to a therapeutic level. In that case, 5mg is a temporary on-ramp, not the destination.